Market Monitor chemicals Brazil 2018

Market Monitor

  • Brésil
  • Chimique/Pharmaceutique

19 juil. 2018

Chemicals businesses dependent on raw materials imports are highly exposed to exchange rate volatility and the looming threat of trade restrictions.

 

Brazil chemicals 2018 pic1

  • In line with the recovery of the Brazilian economy (GDP is forecast to increase 2.4% in 2018 and 3.2% in 2019) the chemicals sector is expected to grow by more than 3% in 2018 and 2019. Both chemicals and pharmaceuticals businesses are expected to improve their results and margins further this year. The level of competition in both the chemicals and pharmaceuticals sectors is high and a concentration process is ongoing - in particular among medium-sized and large players.
  • Turnover in the pharmaceuticals segment increased 6.2% year-on-year in Q1 of 2018, up to BRL 11 billion, which nevertheless was below expectations, due to price adjustments below inflation. That said, stable sales growth is forecast for pharmaceuticals in the coming months. Larger drugstore chains continue to expand and to open new stores, increasingly offering over-the counter (OTC) products like cosmetics and selling natural healthy foods. Another boost could be the potential expansion of the “Aqui tem Farmacia Popular” scheme, which aims to improve public access to medicine, offering subsidized products.
  • Apart from a few large players, most Brazilian chemicals and pharmaceuticals businesses are highly leveraged, which is also the result of previous expansion activities before the recession started in late 2014. While being highly dependent on bank financing, financial institutions are generally willing to provide loans to chemicals and pharmaceutical businesses.

  • Payments take up to 120 days in the chemicals sector and average 90 days in the pharmaceuticals industry, with payment behaviour influenced by consumer spending capacity and public sector spending behaviour. In the pharmaceuticals segment, businesses that are serving the public sector and retailers suffered payment delays in 2016 and in 2017. However, the current economic rebound should help to avoid a further increase in late payment cases, and business insolvencies in both the chemicals and pharmaceuticals sectors are expected to decrease in 2018.

  • Our underwriting stance on the pharmaceuticals sector is generally open, as the main market players are rebounding. However, there are still players that could suffer from restrictions in federal spending for public health, while a continued high unemployment rate could hamper higher growth in the retail segment.

  • Our underwriting stance on the chemicals sector is neutral. The agrichemicals sector remains susceptible to sudden changes in important exogenous factors like climate, market prices and exchange rate fluctuations. In the basic chemicals subsector most raw materials have to be imported, and production costs are therefore exposed to exchange rate volatility and the looming threat of trade restrictions. Petrochemicals performance is impacted by higher oil prices (denominated in USD) and currency volatility, leading to higher costs, while demand has not yet fully rebounded.

 

 

 

Documents connexes

Avertissement

Les informations figurant sur ce site sont uniquement fournies à titre indicatif et ne doivent pas être utilisées à d’autres fins que celles mentionnées. Nous vous remercions de bien vouloir vous reporter aux réglementations et accords en vigueur. Aucune information ne peut être considérée comme créant un droit, une obligation ou engageant la responsabilité d’Atradius y compris pour juger de la moralité d’un ou de plusieurs acheteurs. Si Atradius juge de la moralité d’un acheteur, elle le fait pour le compte de son arbitrage et en aucun cas au bénéfice de ses assurés ou toute autre personne. En aucun cas, Atradius, ses partenaires ou sociétés apparentées, agents ou employés, ne pourront être tenus responsables envers les lecteurs ou toute autre personne pour toute décision ou mesure prise sur la foi des informations contenues dans ces pages, ou pour tous dommages indirects, particuliers ou similaires, même si ces personnes ont été avisées de l’éventualité de tels préjudices.